Advertisement
Review| Volume 230, P293-300, March 01, 2017

Obstructive sleep and atrial fibrillation: Pathophysiological mechanisms and therapeutic implications

Published:December 22, 2016DOI:https://doi.org/10.1016/j.ijcard.2016.12.120

      Highlights

      • Obstructive sleep apnea (OSA) is a significant risk factor for atrial fibrillation (AF).
      • Several mechanisms have been implicated in AF occurrence in OSA patients.
      • Treatment of OSA is an important component of AF management.

      Abstract

      Atrial fibrillation (AF) is the commonest arrhythmia in clinical practice and is associated with increased cardiovascular morbidity and mortality. Obstructive sleep apnea (OSA), a common breathing disorder, is an independent risk factor for AF. Several pathophysiological mechanisms, including apnea-induced hypoxia, intrathoracic pressure shifts, sympathovagal imbalance, atrial remodeling, oxidative stress, inflammation and neurohumoral activation have been implicated in the occurrence of AF in OSA patients. In addition, OSA has been shown to reduce success rates of antiarrhythmic drugs, electrical cardioversion and catheter ablation in AF. Effective prevention of obstructive respiratory events by continuous positive airway pressure ventilation (CPAP) reduces sympathovagal activation and recurrence of AF. The present review describes the relationship between OSA and AF, presents the pathophysiological mechanisms implicating OSA in AF occurrence, and provides an update of the potential therapeutic interventions for patients with OSA and AF.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Go A.S.
        • Hylek E.M.
        • Phillips K.A.
        • et al.
        Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study.
        JAMA. 2001; 285: 2370-2375
        • Stewart S.
        • Hart C.L.
        • Hole D.J.
        • McMurray J.J.
        A population-based study of the long term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.
        Am. J. Med. 2002; 113: 359-364
        • Beyerbach D.M.
        • Zipes D.P.
        Mortality as an endpoint in atrial fibrillation.
        Heart Rhythm. 2004; 1: 8-18
        • Yaranov D.M.
        • Smyrlis A.
        • Usatii N.
        • et al.
        Effect of obstructive sleep apnea on frequency of stroke in patients with atrial fibrillation.
        Am. J. Cardiol. 2015; 115: 461-465
        • Wang T.J.
        • Larson M.G.
        • Levy D.
        • et al.
        Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study.
        Circulation. 2003; 107: 2920-2925
        • Gami A.S.
        • Pressman G.
        • Caples S.M.
        • et al.
        Association of atrial fibrillation and obstructive sleep apnea.
        Circulation. 2004; 110: 364-367
        • Szymański F.M.
        • Płatek A.E.
        • Karpiński G.
        • Koźluk E.
        • Puchalski B.
        • Filipiak K.J.
        Obstructive sleep apnea in patients with atrial fibrillation: prevalence, determinants and clinical characteristics of patients in Polish population.
        Kardiol. Pol. 2014; 72: 716-724
        • Tanigawa T.
        • Yamagishi K.
        • Sakurai S.
        • et al.
        Arterial oxygen desaturation during sleep and atrial fibrillation.
        Heart. 2006; 92: 1854-1855
        • Linz D.
        • Linz B.
        • Hohl M.
        • Böhm M.
        Atrial arrhythmogenesis in obstructive sleep apnea: therapeutic implications.
        Sleep Med. Rev. 2016; 26: 87-94
        • Goudis C.A.
        • Korantzopoulos P.
        • Ntalas I.V.
        • Kallergis E.M.
        • Ketikoglou D.G.
        Obesity and atrial fibrillation: a comprehensive review of the pathophysiological mechanisms and links.
        J. Cardiol. 2015; 66: 361-369
        • Malhotra A.
        • White D.P.
        Obstructive sleep apnoea.
        Lancet. 20 2002; 360: 237-245
        • McNicholas W.T.
        Diagnosis of obstructive sleep apnea in adults.
        Proc. Am. Thorac. Soc. 2008; 5: 154-160
        • Mooe T.
        • Gullsby S.
        • Rabben T.
        • Eriksson P.
        Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery.
        Coron. Artery Dis. 1996; 7: 475-478
        • Mehra R.
        • Benjamin E.J.
        • Shahar E.
        • et al.
        Association of nocturnal arrhythmias with sleep disordered breathing: the sleep heart health study.
        Am. J. Respir. Crit. Care Med. 2006; 173: 910-916
        • Gami A.S.
        • Hodge D.O.
        • Herges R.M.
        • et al.
        Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.
        J. Am. Coll. Cardiol. 2007; 49: 565-571
        • Monahan K.
        • Storfer-Isser A.
        • Mehra R.
        • et al.
        Triggering of nocturnal arrhythmias by sleep-disordered breathing events.
        J. Am. Coll. Cardiol. 2009; 54: 1797-1804
        • Mehra R.
        • Stone K.L.
        • Varosy P.D.
        • et al.
        Nocturnal arrhythmias across a spectrum of obstructive and central sleep disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study.
        Arch. Intern. Med. 2009; 169: 1147-1155
        • Mungan U.
        • Ozeke O.
        • Mavioglu L.
        • et al.
        The role of the preoperative screening of sleep apnoea by Berlin questionnaire and Epworth sleepiness scale for postoperative atrial fibrillation.
        Heart Lung Circ. 2013; 22: 38-42
        • Valenza M.C.
        • Baranchuk A.
        • Valenza-Demet G.
        • Muñoz-Casaubon T.
        • Martin-Navajas J.A.
        • Healey J.
        Prevalence of risk factors for atrial fibrillation and stroke among 1210 patients with sleep disordered breathing.
        Int. J. Cardiol. 2014; 174: 73-76
        • van Oosten E.M.
        • Hamilton A.
        • Petsikas D.
        • et al.
        Effect of preoperative obstructive sleep apnea on the frequency of atrial fibrillation after coronary artery bypass grafting.
        Am. J. Cardiol. 2014; 113: 919-923
        • Zhao L.P.
        • Kofidis T.
        • Lim T.W.
        • et al.
        Sleep apnea is associated with new-onset atrial fibrillation after coronary artery bypass grafting.
        J Crit Care. 2015; 30: 1418.e1-1418.e5
        • Uchôa C.H.
        • Danzi-Soares Nde J.
        • Nunes F.S.
        • et al.
        Impact of OSA on cardiovascular events after coronary artery bypass surgery.
        Chest. 2015; 147: 1352-1360
        • Wong J.K.
        • Maxwell B.G.
        • Kushida C.A.
        • Sainani K.L.
        • et al.
        Obstructive sleep apnea is an independent predictor of postoperative atrial fibrillation in cardiac surgery.
        J. Cardiothorac. Vasc. Anesth. 2015; 29: 1140-1147
        • Cadby G.
        • McArdle N.
        • Briffa T.
        • et al.
        Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort.
        Chest. 2015; 148: 945-952
        • Akyüz A.
        • Akkoyun D.Ç.
        • Değirmenci H.
        • Alp R.
        Atrial fibrillation is associated with increased mean platelet volume and apnea hypopnea index in patients with obstructive sleep apnea.
        Angiology. 2015; 66: 525-530
        • Qaddoura A.
        • Kabali C.
        • Drew D.
        • et al.
        Obstructive sleep apnea as a predictor of atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis.
        Can. J. Cardiol. 2014; 30: 1516-1522
        • Stevenson I.H.
        • Teichtahl H.
        • Cunnington D.
        • Ciavarella S.
        • Gordon I.
        • Kalman J.M.
        Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function.
        Eur. Heart J. 2008; 29: 1662-1669
        • Braga B.
        • Poyares D.
        • Cintra F.
        • et al.
        Sleep-disordered breathing and chronic atrial fibrillation.
        Sleep Med. 2009; 10: 212-216
        • Pepin J.L.
        • Levy P.
        Pathophysiology of cardiovascular risk in sleep apnea syndrome.
        Rev. Neurol. 2002; 158: 785-797
        • Skalidis E.I.
        • Hamilos M.I.
        • Karalis I.K.
        • Chlouverakis G.
        • Kochiadakis G.E.
        • Vardas P.E.
        Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation.
        J. Am. Coll. Cardiol. 2008; 51: 2053-2057
        • Lin Y.K.
        • Lai M.S.
        • Chen Y.C.
        • et al.
        Hypoxia and reoxygenation modulate the arrhythmogenic activity of the pulmonary vein and atrium.
        Clin. Sci. 2012; 122: 121e32
        • Lammers W.J.
        • Kirchhof C.
        • Bonke F.I.
        • Allessie M.A.
        Vulnerability of rabbit atrium to reentry by hypoxia. Role of inhomogeneity in conduction and wavelength.
        Am J Physiol. 1992; 262: H47e55
        • Ogi H.
        • Nakano Y.
        • Niida S.
        • et al.
        Is structural remodeling of fibrillated atria the consequence of tissue hypoxia?.
        Circ. J. 2010; 74: 1815-1821
        • Li M.
        • Yang G.
        • Xie B.
        • Babu K.
        • Huang C.
        Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation.
        J. Int. Med. Res. 2014; 42: 224-230
        • Xu Y.
        • Sharma D.
        • Du F.
        • Liu Y.
        The role of toll-like receptor 2 and hypoxia-induced transcription factor-1alpha in the atrial structural remodeling of non-valvular atrial fibrillation.
        Int. J. Cardiol. 2013; 168: 2940-2941
        • Stevenson I.H.
        • Roberts-Thomson K.C.
        • Kistler P.M.
        • et al.
        Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea.
        Heart Rhythm. 2010; 7: 1263-1270
        • Bradley T.D.
        • Hall M.J.
        • Ando S.I.
        • Floras J.S.
        Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure.
        Chest. 2001; 119: 1827-1835
        • Bradley T.D.
        • Floras J.S.
        Sleep apnea and heart failure, part I: obstructive sleep apnea.
        Circulation. 2003; 107: 1671-1678
        • Orban M.
        • Bruce C.J.
        • Pressman G.S.
        • et al.
        Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure.
        Am. J. Cardiol. 2008; 102: 1557-1561
        • Koshino Y.
        • Villarraga H.R.
        • Orban M.
        • et al.
        Changes in left and right ventricular mechanics during the Mueller maneuver in healthy adults: a possible mechanism for abnormal cardiac function in patients with obstructive sleep apnea.
        Circulation. 2010; 3: 282-289
        • Linz D.
        • Schotten U.
        • Neuberger H.R.
        • Böhm M.
        • Wirth K.
        Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation.
        Heart Rhythm. 2011; 8: 1436-1443
        • Linz D.
        • Hohl M.
        • Ukena C.
        • et al.
        Obstructive respiratory events and premature atrial contractions after cardioversion.
        Eur. Respir. J. 2015; 45: 1332-1340
        • Iwasaki Y.K.
        • Shi Y.
        • Benito B.
        • et al.
        Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea.
        Heart Rhythm. 2012; 9: 1409e16
        • De Vos C.B.
        • Nieuwlaat R.
        • Crijns H.J.
        • et al.
        Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the euro heart survey.
        Eur. Heart J. 2008; 29: 632-639
        • Dimmer C.
        • Tavernier R.
        • Gjorgov N.
        • Van Nooten G.
        • Clement D.L.
        • Jordaens L.
        Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting.
        Am. J. Cardiol. 1998; 82: 22-25
        • Coccagna G.
        • Capucci A.
        • Bauleo S.
        • Boriani G.
        • Santarelli A.
        Paroxysmal atrial fibrillation in sleep.
        Sleep. 1997; 20: 396-398
        • Baranchuk A.
        • Simpson C.S.
        • Redfearn D.P.
        • Fitzpatrick M.
        It's time to wake up! Sleep apnea and cardiac arrhythmias.
        Europace. 2008; 6: 666-667
        • Kneller J.
        • Zou R.
        • Vigmond E.J.
        • Wang Z.
        • Leon L.J.
        • Nattel S.
        Cholinergic atrial fibrillation in a computermodel of a two-dimensional sheet of canine atrial cells with realistic ionic properties.
        Circ. Res. 2002; 90: E73-E87
        • Ghias M.
        • Scherlag B.J.
        • Lu Z.
        • et al.
        The role of ganglionated plexi in apnea-related atrial fibrillation.
        J. Am. Coll. Cardiol. 2009; 54: 2075-2083
        • Kallergis E.M.
        • Goudis C.A.
        • Vardas P.E.
        Atrial fibrillation: a progressive atrial myopathy or a distinct disease?.
        Int. J. Cardiol. 2014; 171: 126-133
        • Zhao J.
        • Xu W.
        • Yun F.
        • et al.
        Chronic obstructive sleep apnea causes atrial remodeling in canines: mechanisms and implications.
        Basic Res. Cardiol. 2014; 109: 427
        • Caples S.M.
        • Somers V.K.
        Sleep-disordered breathing and atrial fibrillation.
        Prog. Cardiovasc. Dis. 2009; 51: 411-415
        • Haϊssaguerre M.
        • Jaıs P.
        • Shah D.C.
        • et al.
        Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.
        N. Engl. J. Med. 1998; 339: 659-666
        • Fung J.W.
        • Li T.S.
        • Choy D.K.
        • et al.
        Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction.
        Chest. 2002; 121: 422-429
        • Alchanatis M.
        • Paradellis G.
        • Pini H.
        • Tourkohoriti G.
        • Jordanoglou J.
        Left ventricular function in patients with obstructive sleep apnoea before and after treatment with nasal continuous positive airway pressure.
        Respiration. 2000; 67: 1632-1666
        • Kraiczi H.
        • Caidahl K.
        • Samuelsson A.
        • Peker Y.
        • Hedner J.
        Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea induced hypoxemia during sleep.
        Chest. 2001; 119: 1085-1091
        • Ramos P.
        • Rubies C.
        • Torres M.
        • et al.
        Atrial fibrosis in a chronic murine model of obstructive sleep apnea: mechanisms and prevention by mesenchymal stem cells.
        Respir. Res. 2014; 15: 54
        • Iwasaki Y.K.
        • Kato T.
        • Xiong F.
        • et al.
        Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model.
        J. Am. Coll. Cardiol. 2014; 64: 2013-2023
        • Dimitri H.
        • Ng M.
        • Brooks A.G.
        • et al.
        Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation.
        Heart Rhythm. 2011; 9: 321-327
        • Can I.
        • Aytemir K.
        • Demir A.U.
        • et al.
        P-wave duration and dispersion in patients with obstructive sleep apnea.
        Int J Cardiol. 1999; 133: e 85-e 89
        • Baranchuk A.
        • Parfrey B.
        • Lim L.
        • et al.
        Interatrial block in patients with obstructive sleep apnea.
        Cardiol. J. 2011; 18: 171-175
        • Gaisl T.
        • Wons A.M.
        • Rossi V.
        • et al.
        Simulated obstructive sleep apnea increases P-wave duration and P-wave dispersion.
        PLoS One. 2016; 11e0152994
        • Lim H.E.
        • Kim Y.H.
        • Kim S.H.
        • et al.
        Impact of obstructive sleep apnea on the atrial electromechanical activation time.
        Circulation. 2009; 73: 249-255
        • Yagmur J.
        • Yetkin O.
        • Cansel M.
        • et al.
        Assessment of atrial electromechanical delay and influential factors in patients with obstructive sleep apnea.
        Sleep Breath. 2012; 16: 83-88
        • Torres G.
        • Sánchez-de-la-Torre M.
        • Barbé F.
        Relationship between OSA and hypertension.
        Chest. 2015; 148: 824-832
        • de Abreu-Silva E.O.
        • Beltrami-Moreira M.
        Sleep apnea: an underestimated cause of resistant hypertension.
        Curr. Hypertens. Rev. 2014; 10: 2-7
        • Zhao L.Q.
        • Liu S.W.
        Atrial fibrillation in essential hypertension: an issue of concern.
        J. Cardiovasc. Med. 2014; 15: 100-106
        • Frey W.C.
        • Pilcher J.
        Obstructive sleep related breathing disorders in patients evaluated for bariatric surgery.
        Obes. Surg. 2003; 13: 676-683
        • Lira A.B.
        • de Sousa Rodrigues C.F.
        Evaluation of oxidative stress markers in obstructive sleep apnea syndrome and additional antioxidant therapy: a review article.
        Sleep Breath. 2016 Jun; 20: 1155-1160
        • De Martino T.
        • El Ghoul R.
        • Wang L.
        • et al.
        Oxidative stress and inflammation differentially elevated in objective versus habitual subjective reduced sleep duration in obstructive sleep apnea.
        Sleep. Apr 12 2016; 39: 1361-1369
        • Korantzopoulos P.
        • Kolettis T.M.
        • Galaris D.
        • Goudevenos J.A.
        The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.
        Int. J. Cardiol. 2007; 115: 135-143
        • Shamsuzzaman A.S.
        • Winnicki M.
        • Lanfranchi P.
        • et al.
        Elevated C-reactive protein in patients with obstructive sleep apnea.
        Circulation. 2002; 105: 2462e4
        • Vgontzas A.N.
        • Papanicolaou D.A.
        • Bixler E.O.
        • Kales A.
        • Tyson K.
        • Chrousos G.P.
        Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity.
        J. Clin. Endocrinol. Metab. 1997; 82: 1313-1316
        • Zouaoui Boudjeltia K.
        • Van Meerhaeghe A.
        • Doumit S.
        • et al.
        Sleep apnoea-hypopnoea index is an independent predictor of high-sensitivity c-reactive protein elevation.
        Respiration. 2006; 73: 243-246
        • Ohga E.
        • Tomita T.
        • Wada H.
        • Yamamoto H.
        • Nagase T.
        • Ouchi Y.
        Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1.
        J. Appl. Physiol. 2003; 94: 179e84
        • Wu N.
        • Xu B.
        • Xiang Y.
        • et al.
        Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis.
        Int. J. Cardiol. 2013; 169: 62-72
        • Møller D.S.
        • Lind P.
        • Strunge B.
        • Pedersen E.B.
        Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea.
        Am. J. Hypertens. 2003; 16: 274e80
        • Linz D.
        • Mahfoud F.
        • Linz B.
        • et al.
        Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea.
        Am. J. Hypertens. 2014; 27: 1293-1300
        • Linz D.
        • Hohl M.
        • Nickel A.
        • et al.
        Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea.
        Hypertension. 2013; 62: 767-774
        • Ehrlich J.R.
        • Hohnloser S.H.
        • Nattel S.
        Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence.
        Eur. Heart J. 2006; 27: 512-518
        • Li D.
        • Shinagawa K.
        • Pang L.
        • et al.
        Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing induced congestive heart failure.
        Circulation. 2001; 104: 2608-2614
        • Reil J.C.
        • Hohl M.
        • Selejan S.
        • et al.
        Aldosterone promotes atrial fibrillation.
        Eur. Heart J. 2012; 33: 2098-2108
        • Tsai C.T.
        • Chiang F.T.
        • Tseng C.D.
        • et al.
        Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.
        J. Am. Coll. Cardiol. 2010; 55: 758-770
        • Kuźniar T.J.
        New approaches to positive airway pressure treatment in obstructive sleep apnea.
        Sleep Med. Clin. 2016; 11: 153-159
        • Henderson L.A.
        • Fatouleh R.H.
        • Lundblad L.C.
        • McKenzie D.K.
        • Macefield V.G.
        Effects of 12 months continuous positive airway pressure on sympathetic activity related brainstem function and structure in obstructive sleep apnea.
        Front. Neurosci. 2016; 10: 90
        • Lundblad L.C.
        • Fatouleh R.H.
        • McKenzie D.K.
        • Macefield V.G.
        • Henderson L.A.
        Brain stem activity changes associated with restored sympathetic drive following CPAP treatment in OSA subjects: a longitudinal investigation.
        J. Neurophysiol. 2015; 114: 893-901
        • Kohler M.
        • Pepperell J.C.T.
        • Casadei B.
        • et al.
        CPAP and measures of cardiovascular risk in males with OSAS.
        Eur. Respir. J. 2008; 32: 1488-1496
        • Mills P.J.
        • Kennedy B.P.
        • Loredo J.S.
        • Dimsdale J.E.
        • Ziegler M.G.
        Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea.
        J. Appl. Physiol. 2006; 100: 343-348
        • Nicholl D.D.
        • Hanly P.J.
        • Poulin M.J.
        • et al.
        Evaluation of continuous positive airway pressure therapy on renin-angiotensin system activity in obstructive sleep apnea.
        Am. J. Respir. Crit. Care Med. 2014; 190: 572-580
        • Lloberes P.
        • Sampol G.
        • Espinel E.
        • et al.
        A randomized controlled study of CPAP effect on plasma aldosterone concentration in patients with resistant hypertension and obstructive sleep apnea.
        J. Hypertens. 2014; 32: 1650-1657
        • Jullian-Desayes I.
        • Joyeux-Faure M.
        • Tamisier R.
        • et al.
        Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials.
        Sleep Med. Rev. 2015; 21: 23-38
        • Denker M.G.
        • Cohen D.L.
        Use of continuous positive airway pressure for sleep apnea in the treatment of hypertension.
        Curr. Opin. Nephrol. Hypertens. 2014; 23: 462-467
        • Feldstein C.A.
        Blood pressure effects of CPAP in nonresistant and resistant hypertension associated with OSA: a systematic review of randomized clinical trials.
        Clin. Exp. Hypertens. 2016; 38: 337-346
        • Butt M.
        • Dwivedi G.
        • Shantsila A.
        • Khair O.A.
        • Lip G.Y.
        Left ventricular systolic and diastolic function in obstructive sleep apnea: impact of continuous positive airway pressure therapy.
        Circ. Heart Fail. 2012; 5: 226-233
        • Bayir P.T.
        • Demirkan B.
        • Bayir O.
        • et al.
        Impact of continuous positive airway pressure therapy on atrial electromechanical delay and P-wave dispersion in patients with obstructive sleep apnea.
        Ann. Noninvasive Electrocardiol. 2014; 19: 226-233
        • Vural M.G.
        • Cetin S.
        • Firat H.
        • Akdemir R.
        • Yeter E.
        Impact of continuous positive airway pressure therapy on left atrial function in patients with obstructive sleep apnoea: assessment by conventional and two-dimensional speckle-tracking echocardiography.
        Acta Cardiol. 2014; 69: 175-184
        • Neilan T.G.
        • Farhad H.
        • Dodson J.A.
        • et al.
        Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation.
        J. Am. Heart Assoc. 2013; 2e000421
        • Holmqvist F.
        • Guan N.
        • Zhu Z.
        • et al.
        Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF).
        Am. Heart J. 2015; 169: 647-654
        • Kanagala R.
        • Murali N.S.
        • Friedman P.A.
        • et al.
        Obstructive sleep apnea and the recurrence of atrial fibrillation.
        Circulation. 2003; 107: 2589-2594
        • Dediu G.N.
        • Dumitrache-Rujinski S.
        • Lungu R.
        • et al.
        Positive pressure therapy in patients with cardiac arrhythmias and obstructive sleep apnea.
        Pneumologia. 2015; 64: 18-22
        • Qureshi W.T.
        • Nasir U.B.
        • Alqalyoobi S.
        • et al.
        Meta-analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea.
        Am. J. Cardiol. 2015; 116: 1767-1773
        • Schlatzer C.
        • Bratton D.J.
        • Craig S.E.
        • Kohler M.
        • Stradling J.R.
        ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
        BMJ Open. 2016; 6e010150
        • Sauer W.H.
        • McKernan M.L.
        • Lin D.
        • Gerstenfeld E.P.
        • Callans D.J.
        • Marchlinski F.E.
        Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation.
        Heart Rhythm. 2006; 3: 1024-1028
        • Jongnarangsin K.
        • Chugh A.
        • Good E.
        • et al.
        Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation.
        J. Cardiovasc. Electrophysiol. 2008; 19: 668-672
        • Matiello M.
        • Nadal M.
        • Tamborero D.
        • et al.
        Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients.
        Europace. 2010; 12: 1084-1089
        • Patel D.
        • Mohanty P.
        • Di Biase L.
        • et al.
        Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure.
        Circ. Arrhythm. Electrophysiol. 2010; 3: 445-451
        • Naruse Y.
        • Tada H.
        • Satoh M.
        • et al.
        Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy.
        Heart Rhythm. 2013; 10: 331-337
        • Fein A.S.
        • Shvilkin A.
        • Shah D.
        • et al.
        Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation.
        J. Am. Coll. Cardiol. 2013; 62: 300-305
        • Mohanty S.
        • Mohanty P.
        • Di Biase L.
        • et al.
        Long-term outcome of catheter ablation in atrial fibrillation patients with coexistent metabolic syndrome and obstructive sleep apnea: impact of repeat procedures versus lifestyle changes.
        J. Cardiovasc. Electrophysiol. 2014; 25: 930-938
        • Szymanski F.M.
        • Filipiak K.J.
        • Platek A.E.
        • et al.
        Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations — a long-term prospective, cross-sectional cohort study.
        Sleep Breath. 2015; 19: 849-856
        • Li L.
        • Wang Z.W.
        • Li J.
        • et al.
        Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies.
        Europace. 2014; 16: 1309-1314
        • Linz D.
        • Av H.
        • Ukena C.
        • et al.
        Effects of renal denervation on atrial arrhythmogenesis.
        Futur. Cardiol. 2014; 10: 813-822
        • Linz D.
        • Mahfoud F.
        • Schotten U.
        • et al.
        Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea.
        Hypertension. 2012; 60: 172-178
        • Witkowski A.
        • Prejbisz A.
        • Florczak E.
        • et al.
        Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.
        Hypertension. 2011; 58: 559-565
        • Li S.
        • Scherlag B.J.
        • Yu L.
        • et al.
        Low-level vagosympathetic stimulation: a paradox and potential new modality for the treatment of focal atrial fibrillation.
        Circ. Arrhythm. Electrophysiol. 2009; 2: 645-651
        • Yu L.
        • Scherlag B.J.
        • Li S.
        • et al.
        Low-level vagosympathetic nerve stimulation inhibits atrial fibrillation inducibility: direct evidence by neural recordings from intrinsic cardiac ganglia.
        J. Cardiovasc. Electrophysiol. 2011; 22: 455-463
        • Gao M.
        • Zhang L.
        • Scherlag B.J.
        • et al.
        Low-level vagosympathetic trunk stimulation inhibits atrial fibrillation in rabbit model of obstructive sleep apnea.
        Heart Rhythm. 2015; 12: 818-824
        • Linz D.
        • Hohl M.
        • Khoshkish S.
        • et al.
        Low-level but not high-level baroreceptor stimulation inhibits atrial fibrillation in a pig model of sleep apnea.
        J. Cardiovasc. Electrophysiol. 2016 May; 27: 1086-1092
        • Soose R.J.
        • Gillespie M.B.
        Upper airway stimulation therapy: a novel approach to managing obstructive sleep apnea.
        Laryngoscope. 2016; 126: S5-S8
        • Strollo Jr., P.J.
        • Soose R.J.
        • Maurer J.T.
        • et al.
        Upper-airway stimulation for obstructive sleep apnea.
        N. Engl. J. Med. 2014; 370: 139-149
        • Abed H.S.
        • Wittert G.A.
        • Leong D.P.
        • et al.
        Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.
        JAMA. 2013; 310: 2050-2060
        • Pathak R.K.
        • Middeldorp M.E.
        • Lau D.H.
        • et al.
        Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study.
        J. Am. Coll. Cardiol. 2014; 64: 2222-2231
        • Pathak R.K.
        • Middeldorp M.E.
        • Meredith M.
        • et al.
        Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY).
        J. Am. Coll. Cardiol. 2015; 65: 2159-2169
        • Szymanski F.M.
        • Filipiak K.J.
        • Platek A.E.
        • Hrynkiewicz-Szymanska A.
        • Karpinski G.
        • Opolski G.
        Assessment of CHADS2 and CHA 2DS 2-VASc scores in obstructive sleep apnea patients with atrial fibrillation.
        Sleep Breath. 2015; 19: 531-537
        • Platek A.E.
        • Szymanski F.M.
        • Filipiak K.J.
        • Kotkowski M.
        • Karpinski G.
        • Opolski G.
        Which components of the CHA2DS2-VASc score are the most important in obstructive sleep apnea patients with atrial fibrillation?.
        Blood Coagul. Fibrinolysis. 2016; 27: 347-351
        • Szymanski F.M.
        • Lip G.Y.
        • Filipiak K.J.
        • Platek A.E.
        • Hrynkiewicz-Szymanska A.
        • Opolski G.
        Stroke risk factors beyond the CHA₂DS₂-VASc score: can we improve our identification of “high stroke risk” patients with atrial fibrillation?.
        Am. J. Cardiol. 2015; 116: 1781-1788